Dr. Deepti Verma, MD

Dr. Verma practices at Lehigh Valley Hospital-Cedar Crest in Allentown, Pennsylvania, part of Thomas Jefferson University.

Dr. Verma's NPI, 1609080282, was assigned on May 10, 2007. Dr. Verma holds Pennsylvania license MD431257.

Dr. Verma's primary practice is Lehigh Valley Hospital-Cedar Crest, at 1200 South Cedar Crest Boulevard, Allentown, PA 18103 in Lehigh County. The practice phone is (610) 402-8000.

Dr. Verma's primary practice is Lehigh Valley Hospital-Cedar Crest in Allentown, Pennsylvania, part of Thomas Jefferson University. Dr. Verma is also affiliated with Lehigh Valley Hospital-Hazleton. The medical group on file is Lehigh Valley Physician Group (LVPG). Dmand AI also links Dr. Verma to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Verma practices, 6 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Verma's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Verma is licensed in Pennsylvania.

CMS data shows 897 Medicare services from Dr. Verma across 6 procedure codes in 2024, for 403 Medicare patients. Medicare paid $83,700 for them.

CMS counts 403 Medicare patients who saw Dr. Verma in 2024. The largest group is 65 to 74, with 148 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 3.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Verma's median patient age at 66, with 52% women.

In 2024, Dr. Verma wrote 270 Medicare Part D claims for 53 patients. 77% of them were for generic drugs. CMS names the drug for 187 of them, across 10 drugs with 11 or more claims each, at $151,756 in total drug cost. In 2023, CMS named 175 claims across 10 drugs.

Dr. Verma accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Verma as offering telehealth.

Dmand AI links 24 papers to Dr. Verma, published from 2010 to 2024. 2013 was the busiest year, with 4. The most frequent topics are NLR Family, Pyrin Domain-Containing 3 Protein, Inflammasomes and Neoplasm Proteins. Dr. Verma has published most often in J Invest Dermatol. Dr. Verma's most frequent co-authors are Jyotirmoy Husayn Das, MD, Jaydeep M. Bhatt, MD and Lori Broderick, MD, PhD.

CMS Open Payments shows 2 general payments to Dr. Verma from 2 drug and device companies in 2016. Food and beverage make up the largest share, 100% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $20.